Duke University
UEI TP7EK8DZV6N5 · NC · SAM.gov record ↗
Obligations by agency
- Department Of Health And Human Services$61.9M
- Department Of Defense$2.6M
- Department Of The Interior$1.3M
- Department Of Veterans Affairs$761K
- National Aeronautics And Space Administration$494K
- Environmental Protection Agency$103K
- Department Of Homeland Security$0
- Department Of Transportation$0
Obligations by NAICS
Monthly obligations
Contracts ending within 18 months (recompete watch)
- 36C24625P1548 ↗$22K
BRPC LAB SERVICES
- Ends
- Sep 10, 2026
- Started
- Sep 11, 2025
- Agency
- Department Of Veterans Affairs
- NAICS
- 541714
- 36C24623P1586 ↗$616K
BRAIN TISSUE PROCESSING WITH DUKE UNIVERSITY
- Ends
- Sep 11, 2026
- Started
- Sep 12, 2023
- Agency
- Department Of Veterans Affairs
- NAICS
- 541714
- 36C24E25C0008 ↗$293K
RNA EXTRACTION AND SEQUENCING
- Ends
- Sep 16, 2026
- Started
- Sep 17, 2025
- Agency
- Department Of Veterans Affairs
- NAICS
- 541720
- 75N94025F00002 ↗$2.9M
NICHD: R&D: BPCA PEDIATRIC DRUG DEVELOPMENT CLINICAL TRIAL INFRASTRUCTURE: SEVERABLE
- Ends
- Sep 18, 2026
- Started
- Sep 19, 2025
- Agency
- National Institutes Of Health
- NAICS
- 541715
- 36C24625P1474 ↗$22K
NEUROIMAGING AND DATA ANALYTICS SERVICES
- Ends
- Sep 24, 2026
- Started
- Sep 25, 2025
- Agency
- Department Of Veterans Affairs
- NAICS
- 541714
- 75D30123F00001 ↗$164K
2023 CLINICAL IMMUNIZATION SAFETY ASSESSMENT (CISA) BASE IDIQ
- Ends
- Sep 26, 2026
- Started
- Sep 27, 2023
- Agency
- Centers For Disease Control And Prevention
- NAICS
- 622110
THE PURPOSE OF THIS NO COST MODIFICATION IS TO CORRECT THE PERIOD OF PERFORMANCE AND CONTRACT DELIVERABLES.
- Ends
- Sep 27, 2026
- Started
- Sep 4, 2023
- Agency
- Food And Drug Administration
- NAICS
- 541714
A STUDY IN MEDICARE ADVANTAGE FOR REAL WORLD EVIDENCE IN CARDIOVASCULAR DISEASE
- Ends
- Sep 28, 2026
- Started
- Sep 27, 2023
- Agency
- Food And Drug Administration
- NAICS
- 541715
TO PERFORM A TARGETED REVIEW OF LITERATURE REGARDING QUALITY OF LIFE OF PATIENTS WITH OAB AND THE USE OF LURN SI-10 MEASURE; AND TO ELICIT THE RELATIVE IMPORTANCE OF LURN SI-10 ITEMS FROM THE PATIENTS? PERSPECTIVE USING A PREFERENCE-ELICITATION INSTR
- Ends
- Sep 28, 2026
- Started
- Sep 25, 2023
- Agency
- Food And Drug Administration
- NAICS
- 541990
- W912HQ25P0096 ↗$206K
IWR - BAYESIAN ENHANCEMENT OF FLOOD RISK MANAGEMENT DEPTH-DAMAGE MODELING. INCORPORATE A HIERARCHICAL BAYESIAN METHODOLOGY TO IMPROVE THE ACCURACY, INTERPRETABILITY, AND GENERALIZABILITY OF PARCEL-SCALE FLOOD DAMAGE ESTIMATION
- Ends
- Sep 28, 2026
- Started
- Sep 29, 2025
- Agency
- Department Of The Army
- NAICS
- 541715
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 36C24625P1548 ↗ | BRPC LAB SERVICES | Department Of Veterans Affairs | 541714 | $22K | Sep 11, 2025 | Sep 10, 2026 |
| 36C24623P1586 ↗ | BRAIN TISSUE PROCESSING WITH DUKE UNIVERSITY | Department Of Veterans Affairs | 541714 | $616K | Sep 12, 2023 | Sep 11, 2026 |
| 36C24E25C0008 ↗ | RNA EXTRACTION AND SEQUENCING | Department Of Veterans Affairs | 541720 | $293K | Sep 17, 2025 | Sep 16, 2026 |
| 75N94025F00002 ↗ | NICHD: R&D: BPCA PEDIATRIC DRUG DEVELOPMENT CLINICAL TRIAL INFRASTRUCTURE: SEVERABLE | National Institutes Of Health | 541715 | $2.9M | Sep 19, 2025 | Sep 18, 2026 |
| 36C24625P1474 ↗ | NEUROIMAGING AND DATA ANALYTICS SERVICES | Department Of Veterans Affairs | 541714 | $22K | Sep 25, 2025 | Sep 24, 2026 |
| 75D30123F00001 ↗ | 2023 CLINICAL IMMUNIZATION SAFETY ASSESSMENT (CISA) BASE IDIQ | Centers For Disease Control And Prevention | 622110 | $164K | Sep 27, 2023 | Sep 26, 2026 |
| 75F40123C00138 ↗ | THE PURPOSE OF THIS NO COST MODIFICATION IS TO CORRECT THE PERIOD OF PERFORMANCE AND CONTRACT DELIVERABLES. | Food And Drug Administration | 541714 | $0 | Sep 4, 2023 | Sep 27, 2026 |
| 75F40123C00209 ↗ | A STUDY IN MEDICARE ADVANTAGE FOR REAL WORLD EVIDENCE IN CARDIOVASCULAR DISEASE | Food And Drug Administration | 541715 | $0 | Sep 27, 2023 | Sep 28, 2026 |
| 75F40123C00183 ↗ | TO PERFORM A TARGETED REVIEW OF LITERATURE REGARDING QUALITY OF LIFE OF PATIENTS WITH OAB AND THE USE OF LURN SI-10 MEASURE; AND TO ELICIT THE RELATIVE IMPORTANCE OF LURN SI-10 ITEMS FROM THE PATIENTS? PERSPECTIVE USING A PREFERENCE-ELICITATION INSTR | Food And Drug Administration | 541990 | $0 | Sep 25, 2023 | Sep 28, 2026 |
| W912HQ25P0096 ↗ | IWR - BAYESIAN ENHANCEMENT OF FLOOD RISK MANAGEMENT DEPTH-DAMAGE MODELING. INCORPORATE A HIERARCHICAL BAYESIAN METHODOLOGY TO IMPROVE THE ACCURACY, INTERPRETABILITY, AND GENERALIZABILITY OF PARCEL-SCALE FLOOD DAMAGE ESTIMATION | Department Of The Army | 541715 | $206K | Sep 29, 2025 | Sep 28, 2026 |
Largest awards
- 75N93019C00050 ↗$9.0M
THIS CONTRACT WILL SUPPORT COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES, BASED ON PRINCIPLES OF INFLUENZA IMMUNITY, THAT ACHIEVE DURABLE, ROBUST
- Ends
- Apr 30, 2027
- Started
- Sep 9, 2019
- Agency
- National Institutes Of Health
- NAICS
- 541715
- 75N93019C00054 ↗$8.9M
EOI::IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19,2025)::EOI COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE
- Ends
- Dec 30, 2030
- Started
- Sep 15, 2019
- Agency
- National Institutes Of Health
- NAICS
- 541715
- 75N93024F00001 ↗$8.2M
EXTERNAL QUALITY ASSURANCE PROGRAM OVERSIGHT LABORATORY (EQAPOL)
- Ends
- Sep 28, 2031
- Started
- Sep 29, 2024
- Agency
- National Institutes Of Health
- NAICS
- 541715
- 75N93025C00006 ↗$5.1M
NONHUMAN PRIMATE CORE HUMORAL IMMUNOLOGY LABORATORY FOR AIDS VACCINE RESEARCH AND DEVELOPMENT
- Ends
- Mar 28, 2032
- Started
- Mar 29, 2025
- Agency
- National Institutes Of Health
- NAICS
- 541715
- 75N94025F00001 ↗$4.8M
NICHD: R&D: BEST PHARMACEUTICALS FOR CHILDREN ACT (BPCA) PEDIATRIC TRIALS NETWORK (PTN): CORE FUNCTION ACTIVITIES - THE CONTRACTOR SHALL ESTABLISH AND MAINTAIN CENTRALIZED TEAMS OF EXPERTS WHO WILL DEVELOP PROTOCOLS AND INFORMED CONSENT FORMS AND
- Ends
- Jun 2, 2027
- Started
- Jun 3, 2025
- Agency
- National Institutes Of Health
- NAICS
- 541715
- 75R60220C00008 ↗$4.4M
DUKE - NATIONAL CORD BLOOD INVENTORY
- Ends
- Sep 2, 2035
- Started
- Jul 9, 2020
- Agency
- Health Resources And Services Administration
- NAICS
- 621991
- 75N93022C00053 ↗$3.4M
ADJUVANT COMPARISON AND CHARACTERIZATION
- Ends
- Apr 29, 2028
- Started
- Aug 31, 2022
- Agency
- National Institutes Of Health
- NAICS
- 541714
- 75N93024F00001 ↗$3.4M
FEASIBILITY FOR DEVELOPMENT OF A LIPOSOME/LNP DISPLAYING AN HIV ENV TRIMER PROTEIN AND CONTAINING/INCORPORATING AN MRNA
- Ends
- Aug 26, 2028
- Started
- Aug 30, 2024
- Agency
- National Institutes Of Health
- NAICS
- 541715
- 75N93026C00005 ↗$3.4M
VIROLOGY QUALITY ASSURANCE (VQA)
- Ends
- Jun 19, 2027
- Started
- Jun 20, 2026
- Agency
- National Institutes Of Health
- NAICS
- 541715
- 75N93019C00015 ↗$3.4M
THIS CONTRACT WILL PROVIDE LABORATORIES PERFORMING VIROLOGIC TESTING FOR NIAID-SPONSORED CLINICAL TRIALS (LABS) WITH A COMPREHENSIVE QUALITY ASSESSMENT PROGRAM FOR VIROLOGIC ASSAYS FOR HIV AND OTHER VIRAL PATHOGENS INCLUDING PROFICIENCY TESTING PROGR
- Ends
- Jun 19, 2026
- Started
- Jun 20, 2019
- Agency
- National Institutes Of Health
- NAICS
- 541715
- 75N94025F00002 ↗$2.9M
NICHD: R&D: BPCA PEDIATRIC DRUG DEVELOPMENT CLINICAL TRIAL INFRASTRUCTURE: SEVERABLE
- Ends
- Sep 18, 2026
- Started
- Sep 19, 2025
- Agency
- National Institutes Of Health
- NAICS
- 541715
- 75N93021C00010 ↗$1.9M
IMMUNOLOGY QUALITY ASSESSMENT (IQA) PROGRAM
- Ends
- Sep 28, 2026
- Started
- Sep 29, 2021
- Agency
- National Institutes Of Health
- NAICS
- 541715
- 75N93025C00002 ↗$1.9M
VIROLOGY CORE LABORATORY
- Ends
- Dec 13, 2026
- Started
- Dec 14, 2024
- Agency
- National Institutes Of Health
- NAICS
- 541715
- 75N93024C00005 ↗$1.5M
PROMOTING T CELL RECOVERY AFTER RADIATION INJURY WITH LONG-ACTING INTERLEUKIN 7
- Ends
- Feb 27, 2027
- Started
- Feb 29, 2024
- Agency
- National Institutes Of Health
- NAICS
- 541714
- 75N93024C00074 ↗$1.4M
EOI::IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE(MARCH 19, 2025)::EOI INNOVATIONS IN FUNCTIONAL B CELL EPITOPE DISCOVERY
- Ends
- Sep 28, 2026
- Started
- Sep 29, 2024
- Agency
- National Institutes Of Health
- NAICS
- 541714
- 140D0422P0227 ↗$1.3M
NATIONAL DATA ARCHIVE ON CHILD ABUSE AND NEGLECT (NDACAN) OPERATION AND MAINTENANCE SERVICES
- Ends
- Sep 28, 2026
- Started
- Sep 25, 2022
- Agency
- Departmental Offices
- NAICS
- 541690
- 75N93022F00001 ↗$1.0M
RESEARCH AND DEVELOPMENT PRODUCT STORAGE AND SHIPPING
- Ends
- Nov 29, 2026
- Started
- Nov 30, 2021
- Agency
- National Institutes Of Health
- NAICS
- 541715
- 75N93019C00053 ↗$764K
19C00053; COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) COMPONENT B: VACCINE MANUFACTURING AND TOXICOLOGY CORE.
- Ends
- Sep 14, 2028
- Started
- Aug 25, 2019
- Agency
- National Institutes Of Health
- NAICS
- 541714
- 75F40125C00053 ↗$750K
THE FOOD AND DRUG ADMINISTRATION (FDA) IS RESPONSIBLE FOR PROTECTING THE PUBLIC HEALTH BY ASSURING THE SAFETY, EFFICACY, AND SECURITY OF HUMAN AND VETERINARY DRUGS, BIOLOGICAL PRODUCTS, MEDICAL DEVICES, OUR NATION?S FOOD SUPPLY, COSMETICS, AND PRODUC
- Ends
- Mar 30, 2028
- Started
- Sep 7, 2025
- Agency
- Food And Drug Administration
- NAICS
- 541714
- 36C24623P1586 ↗$616K
BRAIN TISSUE PROCESSING WITH DUKE UNIVERSITY
- Ends
- Sep 11, 2026
- Started
- Sep 12, 2023
- Agency
- Department Of Veterans Affairs
- NAICS
- 541714
- N3560A26FB105 ↗$546K
SPRING 2026 NROTC MIDSHIPMEN TUITION AND ALLOWABLE FEES
- Ends
- Apr 21, 2026
- Started
- Feb 21, 2026
- Agency
- Department Of The Navy
- NAICS
- 611310
- 75N93022F00001 ↗$388K
TASK AREA A: ADMINISTRATIVE AND OVERALL CLINICAL OPERATIONS SUPPORT AND CONCEPT DEVELOPMENT
- Ends
- Jan 12, 2027
- Started
- Jan 13, 2022
- Agency
- National Institutes Of Health
- NAICS
- 541715
- 80NSSC26P0252 ↗$350K
DECOMPRESSION SICKNESS TESTING - SAT
- Ends
- Feb 16, 2027
- Started
- Feb 16, 2026
- Agency
- National Aeronautics And Space Administration
- NAICS
- 621511
- N3560A25FB016 ↗$309K
SPRING 2025 NROTC MIDSHIPMEN TUITION AND ALLOWABLE FEES
- Ends
- Apr 27, 2025
- Started
- Feb 20, 2025
- Agency
- Department Of The Navy
- NAICS
- 611310
- 36C24E25C0008 ↗$293K
RNA EXTRACTION AND SEQUENCING
- Ends
- Sep 16, 2026
- Started
- Sep 17, 2025
- Agency
- Department Of Veterans Affairs
- NAICS
- 541720
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 75N93019C00050 ↗ | THIS CONTRACT WILL SUPPORT COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES, BASED ON PRINCIPLES OF INFLUENZA IMMUNITY, THAT ACHIEVE DURABLE, ROBUST | National Institutes Of Health | 541715 | $9.0M | Sep 9, 2019 | Apr 30, 2027 |
| 75N93019C00054 ↗ | EOI::IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19,2025)::EOI COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE | National Institutes Of Health | 541715 | $8.9M | Sep 15, 2019 | Dec 30, 2030 |
| 75N93024F00001 ↗ | EXTERNAL QUALITY ASSURANCE PROGRAM OVERSIGHT LABORATORY (EQAPOL) | National Institutes Of Health | 541715 | $8.2M | Sep 29, 2024 | Sep 28, 2031 |
| 75N93025C00006 ↗ | NONHUMAN PRIMATE CORE HUMORAL IMMUNOLOGY LABORATORY FOR AIDS VACCINE RESEARCH AND DEVELOPMENT | National Institutes Of Health | 541715 | $5.1M | Mar 29, 2025 | Mar 28, 2032 |
| 75N94025F00001 ↗ | NICHD: R&D: BEST PHARMACEUTICALS FOR CHILDREN ACT (BPCA) PEDIATRIC TRIALS NETWORK (PTN): CORE FUNCTION ACTIVITIES - THE CONTRACTOR SHALL ESTABLISH AND MAINTAIN CENTRALIZED TEAMS OF EXPERTS WHO WILL DEVELOP PROTOCOLS AND INFORMED CONSENT FORMS AND | National Institutes Of Health | 541715 | $4.8M | Jun 3, 2025 | Jun 2, 2027 |
| 75R60220C00008 ↗ | DUKE - NATIONAL CORD BLOOD INVENTORY | Health Resources And Services Administration | 621991 | $4.4M | Jul 9, 2020 | Sep 2, 2035 |
| 75N93022C00053 ↗ | ADJUVANT COMPARISON AND CHARACTERIZATION | National Institutes Of Health | 541714 | $3.4M | Aug 31, 2022 | Apr 29, 2028 |
| 75N93024F00001 ↗ | FEASIBILITY FOR DEVELOPMENT OF A LIPOSOME/LNP DISPLAYING AN HIV ENV TRIMER PROTEIN AND CONTAINING/INCORPORATING AN MRNA | National Institutes Of Health | 541715 | $3.4M | Aug 30, 2024 | Aug 26, 2028 |
| 75N93026C00005 ↗ | VIROLOGY QUALITY ASSURANCE (VQA) | National Institutes Of Health | 541715 | $3.4M | Jun 20, 2026 | Jun 19, 2027 |
| 75N93019C00015 ↗ | THIS CONTRACT WILL PROVIDE LABORATORIES PERFORMING VIROLOGIC TESTING FOR NIAID-SPONSORED CLINICAL TRIALS (LABS) WITH A COMPREHENSIVE QUALITY ASSESSMENT PROGRAM FOR VIROLOGIC ASSAYS FOR HIV AND OTHER VIRAL PATHOGENS INCLUDING PROFICIENCY TESTING PROGR | National Institutes Of Health | 541715 | $3.4M | Jun 20, 2019 | Jun 19, 2026 |
| 75N94025F00002 ↗ | NICHD: R&D: BPCA PEDIATRIC DRUG DEVELOPMENT CLINICAL TRIAL INFRASTRUCTURE: SEVERABLE | National Institutes Of Health | 541715 | $2.9M | Sep 19, 2025 | Sep 18, 2026 |
| 75N93021C00010 ↗ | IMMUNOLOGY QUALITY ASSESSMENT (IQA) PROGRAM | National Institutes Of Health | 541715 | $1.9M | Sep 29, 2021 | Sep 28, 2026 |
| 75N93025C00002 ↗ | VIROLOGY CORE LABORATORY | National Institutes Of Health | 541715 | $1.9M | Dec 14, 2024 | Dec 13, 2026 |
| 75N93024C00005 ↗ | PROMOTING T CELL RECOVERY AFTER RADIATION INJURY WITH LONG-ACTING INTERLEUKIN 7 | National Institutes Of Health | 541714 | $1.5M | Feb 29, 2024 | Feb 27, 2027 |
| 75N93024C00074 ↗ | EOI::IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE(MARCH 19, 2025)::EOI INNOVATIONS IN FUNCTIONAL B CELL EPITOPE DISCOVERY | National Institutes Of Health | 541714 | $1.4M | Sep 29, 2024 | Sep 28, 2026 |
| 140D0422P0227 ↗ | NATIONAL DATA ARCHIVE ON CHILD ABUSE AND NEGLECT (NDACAN) OPERATION AND MAINTENANCE SERVICES | Departmental Offices | 541690 | $1.3M | Sep 25, 2022 | Sep 28, 2026 |
| 75N93022F00001 ↗ | RESEARCH AND DEVELOPMENT PRODUCT STORAGE AND SHIPPING | National Institutes Of Health | 541715 | $1.0M | Nov 30, 2021 | Nov 29, 2026 |
| 75N93019C00053 ↗ | 19C00053; COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) COMPONENT B: VACCINE MANUFACTURING AND TOXICOLOGY CORE. | National Institutes Of Health | 541714 | $764K | Aug 25, 2019 | Sep 14, 2028 |
| 75F40125C00053 ↗ | THE FOOD AND DRUG ADMINISTRATION (FDA) IS RESPONSIBLE FOR PROTECTING THE PUBLIC HEALTH BY ASSURING THE SAFETY, EFFICACY, AND SECURITY OF HUMAN AND VETERINARY DRUGS, BIOLOGICAL PRODUCTS, MEDICAL DEVICES, OUR NATION?S FOOD SUPPLY, COSMETICS, AND PRODUC | Food And Drug Administration | 541714 | $750K | Sep 7, 2025 | Mar 30, 2028 |
| 36C24623P1586 ↗ | BRAIN TISSUE PROCESSING WITH DUKE UNIVERSITY | Department Of Veterans Affairs | 541714 | $616K | Sep 12, 2023 | Sep 11, 2026 |
| N3560A26FB105 ↗ | SPRING 2026 NROTC MIDSHIPMEN TUITION AND ALLOWABLE FEES | Department Of The Navy | 611310 | $546K | Feb 21, 2026 | Apr 21, 2026 |
| 75N93022F00001 ↗ | TASK AREA A: ADMINISTRATIVE AND OVERALL CLINICAL OPERATIONS SUPPORT AND CONCEPT DEVELOPMENT | National Institutes Of Health | 541715 | $388K | Jan 13, 2022 | Jan 12, 2027 |
| 80NSSC26P0252 ↗ | DECOMPRESSION SICKNESS TESTING - SAT | National Aeronautics And Space Administration | 621511 | $350K | Feb 16, 2026 | Feb 16, 2027 |
| N3560A25FB016 ↗ | SPRING 2025 NROTC MIDSHIPMEN TUITION AND ALLOWABLE FEES | Department Of The Navy | 611310 | $309K | Feb 20, 2025 | Apr 27, 2025 |
| 36C24E25C0008 ↗ | RNA EXTRACTION AND SEQUENCING | Department Of Veterans Affairs | 541720 | $293K | Sep 17, 2025 | Sep 16, 2026 |
Subsidiaries under this parent
- Private Diagnostic Clinic, Pllc ($7.6M)